Depressive Symptoms, omega-6:omega-3 Fatty Acids, and Inflammation in Older Adults

Address correspondence and reprint requests to: Janice K. Kiecolt-Glaser, PhD, E-mail: Kiecolt-Glaser.1{at}osu.edu.

	Abstract

Objective: To address how interactions between polyunsaturated fatty acid (PUFA) levels and depressive symptoms were related to proinflammatory cytokine synthesis. Depression and stress promote proinflammatory cytokine production. Dietary intakes of omega-3 (n-3) and omega-6 (n-6) PUFAs also influence inflammation; high n-6:n-3 ratios enhance proinflammatory cytokine production, although n-3 has anti-inflammatory properties. Methods: Blood samples from 43 older adults (mean age = 66.67 years, SD = 10.09) provided data on PUFAs and tumor necrosis factor (TNF)-, interleukin (IL)-6, and IL-6 soluble receptor (sIL-6r). Depressive symptoms were assessed by the Center for Epidemiological Studies Depression Scale. Results: Depressive symptoms and n-6:n-3 ratios worked together to enhance proinflammatory cytokines beyond the contribution provided by either variable alone, with substantial variance explained by their interaction: 13% for IL-6 and 31% for TNF-, whereas full models accounted for 18% and 40%, respectively. Although predicted cytokine levels were consistent across n-6:n-3 ratios with low depressive symptoms, higher n-6:n-3 ratios were associated with progressively elevated TNF- and IL-6 levels as depressive symptoms increased. Higher levels of sIL-6r were associated with higher n-6:n-3 ratios. Six individuals who met the criteria for major depressive disorder had higher n-6:n-3 ratios and TNF-, IL-6, and sIL-6r levels than those who did not meet the criteria; excluding these six individuals reduced the variance explained by the depressive symptoms and n-6:n-3 ratio interaction. Conclusions: Diets with high n-6:n-3 PUFA ratios may enhance the risk for both depression and inflammatory diseases.

Key Words: depression, proinflammatory cytokines, omega-3, psychoneuroimmunology

This article has been cited by other articles:

				R. M. Carney, K. E. Freedland, E. H. Rubin, M. W. Rich, B. C. Steinmeyer, and W. S. Harris Omega-3 Augmentation of Sertraline in Treatment of Depression in Patients With Coronary Heart Disease: A Randomized Controlled Trial JAMA, October 21, 2009; 302(15): 1651 - 1657. [Abstract] [Full Text] [PDF]

				J. K. Kiecolt-Glaser Psychoneuroimmunology: Psychology's Gateway to the Biomedical Future Perspectives on Psychological Science, July 1, 2009; 4(4): 367 - 369. [Abstract] [Full Text] [PDF]

				M. B. Howren, D. M. Lamkin, and J. Suls Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis Psychosom Med, February 1, 2009; 71(2): 171 - 186. [Abstract] [Full Text] [PDF]

				A. A. Amin, R. A. Menon, K. J. Reid, W. S. Harris, and J. A. Spertus Acute Coronary Syndrome Patients With Depression Have Low Blood Cell Membrane Omega-3 Fatty Acid Levels Psychosom Med, October 1, 2008; 70(8): 856 - 862. [Abstract] [Full Text] [PDF]